Breaking News

Cephalon Completes Mepha Acquisition

Cephalon, Inc. has completed its acquisition of Mepha, a Swiss-based pharmaceutical company, for approximately $615.4 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cephalon, Inc. has completed its acquisition of Mepha, a Swiss-based pharmaceutical company, for approximately $615.4 million. Mepha is now a wholly-owned subsidiary of Cephalon. “We are proud to include Mepha as part of the Cephalon family. Mepha has a strong reputation for high quality products and services that deliver value to patients and healthcare professionals,” said Frank Baldino, Jr., Ph.D., chairman and chief executive officer of Cephalon. “This acquisition expands our presence in...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters